Atai Beckley N.V. (ATAI) — 10-Q Filings

10-Q Filings (6)

• Atai Beckley's Losses Widen Amid R&D Spend, Fair Value Adjustments — Nov 12, 2025 Risk: high
  Atai Beckley N.V. reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $115.309 million, up from $111.058 million
• ATAI Narrows Q2 Loss to $27.7M, Boosts Cash Reserves — Aug 14, 2025 Risk: medium
  ATAI Life Sciences N.V. reported a net loss of $27.7 million for the three months ended June 30, 2025, a significant improvement from the $57.3 million net loss
• ATAI Life Sciences Files Q1 2025 10-Q — May 14, 2025 Risk: medium
  ATAI Life Sciences N.V. filed its Q1 2025 10-Q report on May 14, 2025, detailing its financial performance for the period ending March 31, 2025. The report incl
• ATAI Life Sciences Files Q3 2024 10-Q — Nov 13, 2024 Risk: medium
  ATAI Life Sciences N.V. filed its 10-Q for the period ending September 30, 2024. The company reported on its financial position and business operations, includi
• ATAI Life Sciences Files Q2 2024 10-Q — Aug 13, 2024 Risk: medium
  ATAI Life Sciences N.V. filed its 10-Q for the period ending June 30, 2024. The company reported its financial position and operational highlights. Key entities
• ATAI Life Sciences N.V. Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk: medium
  ATAI Life Sciences N.V. (ATAI) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. ATAI Life Sciences N.V. filed a 10-Q report for the period ending M

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX